Internal Medicine, Pulmonary Disease · Melrose, MA
NPI
1740501550
Since 2010
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
5
Medicare group memberships
Hospitals
4
Hospital affiliations
585 Lebanon St
Melrose, MA, 02176
Phone (781) 979-3000
Groups this clinician bills Medicare through
Medicare paid, 2024
$193K
2,657 services
Medicare patients, 2024
916
Average age 77
Drug cost, 2024
$1.7M
4,833 prescriptions
Company payments, 2025
$127
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jingli Ma was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 453 times for 332 patients. In total Jingli Ma billed 2,657 services in 32 codes, and Medicare paid $193K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-01-05.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 453 | 332 | $13.82 | $6,260 |
| 99213 Office E&M - Established | Office | 431 | 308 | $72.75 | $31K |
| 99214 Office E&M - Established | Office | 354 | 237 | $106.21 | $38K |
| 99291 Critical Care E&M | Facility | 228 | 100 | $173.53 | $40K |
| 99222 Hospital E&M - Initial | Facility | 222 | 205 | $105.08 | $23K |
| 94729 Pulmonary Function Testing | Facility | 155 | 155 | $6.71 | $1,040 |
| 94060 Pulmonary Function Testing | Facility | 145 | 145 | $7.77 | $1,126 |
| 99204 Office E&M - New | Office | 127 | 127 | $130.54 | $17K |
| 99233 Hospital E&M - Subsequent | Facility | 112 | 90 | $95.85 | $11K |
| 99221 Hospital E&M - Initial | Facility | 105 | 92 | $65.19 | $6,845 |
| 94726 Pulmonary Function Testing | Facility | 103 | 103 | $9.72 | $1,002 |
| 99223 Hospital E&M - Initial | Facility | 70 | 66 | $141.99 | $9,939 |
| G0296 Counseling visit to discuss need for lung cancer screening using low dose ct scan (ldct) (service is for eligibility determination and shared decision making) | Office | 60 | 56 | $28.86 | $1,732 |
| 99232 Hospital E&M - Subsequent | Facility | 34 | 27 | $65.69 | $2,233 |
| 94010 Pulmonary Function Testing | Facility | 16 | 16 | $6.30 | $101 |
By year: 2022 $200K for 2,329 services; 2023 $209K for 2,612 services; 2024 $193K for 2,657 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jingli Ma prescribed most often to Medicare patients was Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter), with 975 prescriptions and refills. In total Jingli Ma wrote 4,833 Medicare prescriptions that cost $1.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 975 | 1,335 | 208 | $838K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 636 | 744 | 221 | $21K |
| Prednisone Generic | 572 | 679 | 246 | $2,402 |
| Wixela Inhub Fluticasone Propion/Salmeterol | 378 | 434 | 84 | $49K |
| Roflumilast Generic | 297 | 411 | 63 | $31K |
| Azithromycin Generic | 290 | 421 | 136 | $2,036 |
| Incruse Ellipta Umeclidinium Bromide | 190 | 261 | 51 | $88K |
| Spiriva Respimat Tiotropium Bromide | 162 | 220 | 43 | $114K |
| Breo Ellipta Fluticasone/Vilanterol | 158 | 245 | 35 | $92K |
| Montelukast Sodium Generic | 112 | 258 | 30 | $1,961 |
| Budesonide-Formoterol Fumarate Budesonide/Formoterol Fumarate | 109 | 163 | 35 | $36K |
| Doxycycline Hyclate Generic | 105 | 105 | 81 | $468 |
| Ventolin Hfa Albuterol Sulfate | 89 | 106 | 33 | $6,469 |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 84 | 118 | 30 | $14K |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 76 | 100 | 13 | $44K |
Brand drugs: 2,693 claims; generic drugs: - claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jingli Ma $127 ($127 in general payments such as food, travel and fees) from 3 companies. The largest payer was Sanofi-Aventis U.S. LLC with $57.48.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.